Outcome of hemato-oncologic patients with and without stem cell transplantation in a medical ICU

European Journal of Medical Research

Volumn 12, Issue 8, 2007, Pages 323-330

  Bruennler, Tanja ^a,b   Mandraka, F ^a   Zierhut, S ^a   Siebeg, S ^a   Wrede, C ^a   Klebl, F ^a   Holler, E ^a   Salzberger, B ^a   Schoelmerich, J ^a   Langgartner, J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Critical care; Hematologic; Intensive care unit; Malignancy; Mortality; Outcome; Stem cell transplantation

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER MORTALITY; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRITICAL ILLNESS; DRUG MEGADOSE; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; GERMANY; HEMATOLOGIC NEOPLASMS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 34548411378     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Sculier JP, Markiewicz E. Medical cancer patients and intensive care. Anticancer Res. 1991 Nov/Dec; 11(6): 2171-4.
2. Hauser MJ, Tabak J, Baier H. Survival of patients with cancer in a medical critical care unit. Arch Intern Med. 1982 Mar; 142(3): 527-9.
3. Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit: Outcome in patients with hematologic malignancy. Am J Med. 1983 Sep; 75(§): 402-8.
4. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992 Feb; 67(2): 117-22.
5. Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer. 1997 Jun; 33(7): 1031-7.
6. Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med. 1990; 16(5): 291-7.
7. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis. 1992 Mar; 145(3): 510-4.
8. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis. 1988 Mar; 137(3): 682-7.
9. Dees A, Ligthart JL, van Putten WL, Planting AS, Stoter G. Mechanical ventilation in cancer patients. Analysis of clinical data and outcome. Neth J Med. 1990 Dec; 37(5-6): 183-188.
10. Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med. 1989 Jan; 17(1):4-6.
11. Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA. Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med. 1996 Jun; 44(5): 254-60.
12. Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C. Acute respiratory failure in severe hematologic disorders. Crit Care Med. 1984 Jan; 12(1): 26-8.
13. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant. 1993 Nov; 12(5): 501-7.
14. Groeger JS, White P, Jr., Nierman DM, Glassman J, Shi W, Horak D, et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol. 1999 Mar; 17(3): 991-7.
15. Hinds CJ, Martin R, Quinton P. Intensive care for patients with medical complications of haematological malignancy: is it worth it? Schweiz Med Wochenschr. 1998 Sep 26; 128(39): 1467-73.
16. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med. 2000 Apr; 28(4):1014-7.
17. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998 Apr; 21(7): 697-704.
18. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ. Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 1986; 12: 317-324.
19. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ. Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J (Clin Res Ed). 1988 Apr 9; 296 (6629): 1025-9.
20. Paz HL, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest. 1993 Aug; 104(2): 527-31.
21. Peters SG, Meadows JA, 3rd, Gracey DR. Outcome of respiratory failure in hematologic malignancy. Chest. 1988 Jul; 94(1): 99-102.
22. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998 Sep; 158(3): 876-84.
23. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996 Oct 15; 125(8): 625-33.
24. Torrecilla C, Cortes JL, Chamorro C, Rubio JJ, Galdos P, Dominguez de Villota E. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med. 1988; 14(4): 393-8.
25. Tremblay LN, Hyland RH, Schouten BD, Hanly PJ. Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med. 1995 Feb; 18(1):19-24.
26. Kress JP, Christenson J, Pohhnan AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 1999 Dec; 160(6): 1957-61.
27. Johnson MH, Gordon PW, Fitzgerald FT. Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score. Crit Care Med. 1986 Aug; 14(8): 693-7.
28. Guiguet M, Blot F, Escudier B, Antoun S, Leclercq B, Nitenberg G. Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med. 1998 Mar; 26(3): 488-93.
29. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct; 13(10): 818-29.
30. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama. 1993 Dec 22-29; 270(24): 2957-63.
31. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000 May; 28(5): 1322-8.
32. Groeger JS, Lemeshow S, Price K, Nierman DM, White P, Klar J, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol. 1998 Feb; 16(2): 761-70.
33. Evison J, Rickenbacher P, Ritz R, Gratwohl A, Haberthur C, Elsasser S, et al. Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly. 2001 Dec 22; 131(47-48): 681-6.
34. Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002 Sep; 28(9): 1294-1300.
35. Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med. 2002 Oct; 30(10): 2260-70.
36. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003 Jan; 31(1): 104-12.
37. Gruson D, Vargas F, Hilbert G, Bui N, Maillot T, Mayet T, et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med. 2004 May; 30(5): 965-71.
38. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med. 2001 Mar; 29(3): 519-25.
39. Silfvast T, Pettila V, Ihalainen A, Elonen E. Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand. 2003 Mar; 47(3): 301-6.
40. Hilbert G, Gruson D, Vargas F, Valentino R, Chene G, Boiron JM, et al. Noninvasive continuous positive airway pressure in neutropenic patiens with acute respiratory failure requiring ICU admission. Crit Care Med. 2000 Sep; 28(9): 3185-90.
41. Groeger, JS, Bach, PB. Consider saying yes. Crit Care Med. 2003 Jan; 31(1): 320-1.